Source link : https://newshealth.biz/health-news/trial-questions-continuous-maintenance-in-newly-diagnosed-myeloma/
For patients with standard-risk, newly diagnosed multiple myeloma, a phase III trial showed that maintenance therapy with continuous lenalidomide did not significantly improve overall survival versus fixed-duration lenalidomide. These patients did not undergo upfront autologous stem cell transplantation and received induction treatment with a proteasome inhibitor and lenalidomide. These results show the value of conducting […]
The post Trial Questions Continuous Maintenance in Newly Diagnosed Myeloma first appeared on News Health.
—-
Author : News Health
Publish date : 2026-07-15 21:00:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8